Skip to content

Surgical Management of Chronic Subdural Hematoma: Clinical Outcomes Following Single VS Double Burr Holes Evacuation

Surgical Management of Chronic Subdural Hematoma: Clinical Outcomes Following Single VS Double Burr Holes Evacuation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07688473
Enrollment
30
Registered
2026-07-07
Start date
2022-01-01
Completion date
2026-12-31
Last updated
2026-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Subdural Hematoma

Brief summary

This study aims to evaluate and compare the clinical and radiological outcomes of patients with chronic subdural hematoma (CSDH) undergoing surgical evacuation using either single or double burr-hole craniostomy. The comparison focuses on key outcome measures including recurrence rate, postoperative complications, neurological improvement, length of hospital stay, and overall functional recovery, in order to determine the most effective and safe surgical technique.

Interventions

PROCEDUREChronic Subdural Hematoma Evacuation

Single burr-hole technique: A single burr hole was made over the maximum thickness of the hematoma followed by dural opening, irrigation with warm saline, and placement of a drain. Double burr-hole technique: Two burr holes were created (frontal and parietal), allowing more extensive irrigation and evacuation of the hematoma, followed by drain placement.

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged ≥18 years * Radiologically confirmed chronic subdural hematoma by CT and/or MRI * Symptomatic patients indicated for surgical evacuation * Patients treated by burr-hole craniostomy (single or double)

Exclusion criteria

* Acute or subacute subdural hematomas * Patients managed by craniotomy flap * Uncorrected coagulopathy * Patients on anticoagulant or antiplatelet therapy without proper perioperative management * Patients with severe comorbid conditions significantly affecting outcomes

Design outcomes

Primary

MeasureTime frameDescription
Recurrence6 monthsre-accumulation requiring re-operation

Secondary

MeasureTime frameDescription
Infection6 monthsinvasion and multiplication of pathogenic microorganisms in a host, causing a local or systemic immune response, which may or may not result in clinical disease.
Seizures6 monthssudden, uncontrolled electrical disturbance in the brain that can cause changes in behavior, movement, sensation, consciousness, or autonomic function
Pneumocephalus6 monthspresence of air within the intracranial cavity
Glasgow Coma Scale6 monthsevaluate the level of consciousness in patients with acute brain injury by assessing three components: eye opening, verbal response, and motor response.score ranges from 3 to 15, with lower scores indicating more severe impairment of consciousness.
Motor Power6 monthsstrength generated by voluntary contraction of a muscle or muscle group and is assessed during neurological examination to evaluate the integrity of the motor system. It is commonly graded using the Medical Research Council (MRC) Muscle Strength Scale.ranging from 0 (no contraction) to 5 (normal strength), with higher vlaues indicating better outcomes.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 8, 2026